Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
So as a long suffering Hvivo follower, who agreed to put my trust in Cathal, I need 35p to break even. So I wish all the very best to the team to make the best return on what they are doing. Hopefully some of us other will eventually benefit.
See also For the application process.
https://www.gov.uk/guidance/apply-for-a-licence-to-market-a-medicine-in-the-uk
See this on UK Gov 2014 guidance. Still valid as far as I can see.
https://www.gov.uk/government/news/cutting-edge-drugs-to-be-fast-tracked-to-patients
I find it fascinating and an illustration of how fast things change when the RNS of 6th April had this statement at the bottom of the release! “The Group's revenues are not expected to be materially affected this year as a direct result of the Covid-19 pandemic”. Not sure they meant it in the way it has turned out!
Antigen now has prominence yes, but antibody needed too. Not just about immunity or not. It’s vital data to understand how far into the population the virus has spread asymptomatically. That penetration is important to judge how best too manage “normality” post lockdown.
Researchers found patients recovered from CV19 and tested clear, finding virus is reactivating! The never ending story?
https://www.bloomberg.com/news/articles/2020-04-09/coronavirus-may-reactivate-in-cured-patients-korean-cdc-says
If PHE bought a million tests as stated a few weeks back, then at 20,000 tests a day, that’s 50 days supply. This is not about supply. This is about lab equipment and people capacity to process tests at volume and pace. In addition as the virus RNA changes over time, tests bought three weeks ago may no longer be as good. So buying In frequent blocks will be the best policy to stay on top of virus change.
“IQ-AI Excited By New Technology, Will Form "Backbone" Of New Products“
Just speculating. Maybe they are modifying their underlying imaging AI technology, as referred to here for the brain, to measure lung damage resulting from CV19 so treatments can be designed properly? Some information leaking out? Just my opinion.
https://www.middleeasteye.net/news/coronavirus-turkey-faulty-chinese-kits-not-use
More grist to the mill.
https://eu.usatoday.com/story/news/health/2020/03/19/coronavirus-what-acute-respiratory-distress-syndrome-ards/5066412002/
https://www.healthline.com/health-news/heres-what-happens-to-the-body-after-contracting-the-coronavirus#COVID-19-affects-lungs
https://emcrit.org/ibcc/COVID19/
https://www.healio.com/pulmonology/critical-care/news/online/%7B396c0e9d-c9a4-473a-a264-900eb414dd0a%7D/study-identifies-factors-associated-with-ards-in-covid-19
https://www.inquirer.com/health/coronavirus/coronavirus-ards-acute-respiratory-distress-syndrome-pneumonia-penn-rutgers-20200317.html
Any more evidence needed?
Just spotted this. https://www.brunel.ac.uk/news-and-events/news/articles/Manufacturers-needed-for-rapid-roll-out-of-Coronavirus-testSmall kit attached to mobile app for home use. Any mileage here?
Having read a bit around this I suspect this is another tool in the toolbox to deal with acute respiratory distress syndrome (ARS) and its cause, capillary leakage. This leakage stems from inflammation of cells in the blood vessels. Seems to me Traumakine acts as an anti inflammatory by blocking an inflammatory chemical pathway so may either have its impact enhanced by AOC3, or it works on another part of the inflammation pathway to block capillary leakage in people not susceptible to Traumakine. Maybe using both together in a single dose helps a larger population with ARDS, thus increasing the size of the target population, and market. Maybe AOC3 blocking action is not undermined by steroids ? As has been said, it would be good if the CEO explained the real significance of AOC3 in words of less than three syllables!
My Charles Stanley Account now has Open Orphan Shares in it.
My 09:47 buy at 6.44 showing as a sell!
I think another factor in their future success will be their adoption of a "per use" model to generate a smooth, long term revenue stream from each customer, rather than relying on long lead time big sales and then ongoing support and upgrades for future revenue.
See also this article
https://www.wired.co.uk/article/uk-power-cut-batteries-national-grid
Li based batteries will be needed in greater numbers around the world over time to back up grid power supply. Better than generators. No CO2 and fast reaction time to demand change.